In SCLC, using a multiplexed immunofluorescence assay, researchers found that patients with high expression of MHC-I had more infiltration of CD3+ T cells and CD45+/PD-L1+ immune cells in intratumoral regions than those with low or no expression of MHC-I (40). Here, CD274 is linked to small cell lung carcinoma.